Safety and efficacy of conversion therapy for esophageal squamous cell carcinoma.

被引：0
|
作者：
Tsuji, Takayuki
Kawakubo, Hirofumi
Takeuchi, Masashi
Matsuda, Satoru
Fukuda, Kazumasa
Nakamura, Rieko
Kitagawa, Yuko
机构：
[1] Keio Univ, Sch Med, Shinjuku Ku, Tokyo, Japan
[2] Keio Univ, Div Gen & Gastroenterol Surg, Sch Med, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
362
引用
收藏
页码：362 / 362
页数：1
相关论文
共 50 条
  • [31] The usefulness of ctDNA and exosome DNA as biomarkers in esophageal squamous cell carcinoma.
    Nakai, Tomoki
    Kitahata, Yuji
    Nakamura, Yuki
    Motobayashi, Hideki
    Takemoto, Norio
    Ojima, Toshiyasu
    Hayata, Keiji
    Iwaya, Takeshi
    Hiraki, Hayato
    Nishizuka, Satoshi
    Kawai, Manabu
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 388 - 388
  • [32] Treatment strategy for lateral spreading superficial esophageal squamous cell carcinoma.
    Kawakubo, Hirofumi
    Suda, Koichi
    Mayangai, Shyuhei
    Nakamura, Rieko
    Wada, Norihito
    Kitagawa, Yuko
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [33] Tumor budding as a useful prognostic marker in esophageal squamous cell carcinoma.
    Roh, MS
    Lee, JIK
    Choi, PJ
    Kwon, HC
    Kim, HK
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 363S - 363S
  • [34] Radiofrequency ablation for pulmonary metastases from esophageal squamous cell carcinoma.
    Shigaki, Hironobu
    Kosumi, Keisuke
    Tokunaga, Ryuma
    Harada, Kazuto
    Kurashige, Junji
    Iwatsuki, Masaaki
    Baba, Yoshifumi
    Sakamoto, Yasuo
    Miyamoto, Yuji
    Yoshida, Naoya
    Baba, Hideo
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [35] Gender differences in hormonal statuses of patients with esophageal squamous cell carcinoma.
    Kolesnikov, Evgeniy N.
    Kit, Oleg Ivanovich
    Frantsiyants, Elena Mikhaylovna
    Bandovkina, Valeria
    Kozlova, Margarita
    Cheryarina, Natalia D.
    Mezentsev, Stanislav Stanislavovich
    Snezhko, Alexander V.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [36] Roles of chloride channel protein 2 in esophageal squamous cell carcinoma.
    Mitsuda, Masato
    Shiozaki, Atsushi
    Kosuga, Toshiyuki
    Shimizu, Hiroki
    Kudou, Michihiro
    Arita, Tomohiro
    Yamamoto, Yusuke
    Konishi, Hirotaka
    Morimura, Ryo
    Kuriu, Yoshiaki
    Ikoma, Hisashi
    Kubota, Takeshi
    Fujiwara, Hitoshi
    Okamoto, Kazuma
    Otsuji, Eigo
    CANCER SCIENCE, 2021, 112 : 631 - 631
  • [37] mRNA expression pattern study of esophageal basaloid squamous cell carcinoma.
    Li, Yan
    Liu, Linxiu
    Xie, Tongji
    Pan, Yi
    Cheng, Na
    Guo, Changyuan
    Xue, Xuemin
    Zeng, Hua
    Xue, Liyan
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16062 - E16062
  • [38] A landscape of circulating tumor DNA in esophageal adenocarcinoma and squamous cell carcinoma.
    Mody, Kabir
    Manochakian, Rami
    Ahn, Daniel H.
    Roberts, Ali
    Nagy, Rebecca
    Lanman, Richard B.
    Kasi, Pashtoon Murtaza
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [39] Squamous cell carcinoma as the most common oral carcinoma. Diagnosis and therapy
    Balakirski, G.
    Hoelzle, F.
    Megahed, M.
    HAUTARZT, 2014, 65 (05): : 390 - 392
  • [40] Safety and short-term efficacy of adjuvant nivolumab after neoadjuvant docetaxel, cisplatin, and fluorouracil for locally advanced esophageal squamous cell carcinoma.
    Okunaka, Mashiro
    Kotani, Daisuke
    Sato, Kazuma
    Fujiwara, Naoto
    Mishima, Saori
    Shitara, Kohei
    Fujita, Takeo
    Kojima, Takashi
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 271 - 271
12345